Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SIGAthis companySIGA Technologies, Inc.	$3.13	18.52×	2.2×	4.62×	9.14×	203.0%	68.6%	25.1%	24.6%	11.7%	9.0%	9.9%	0×	-4.99×	0×	11.83×	9.9%	1	12.87	3	B
AQSTAquestive Therapeutics, Inc.	$3.66	-8.5×	-23.41×	17.69×	-12.07×	-157.6%	61.5%	-156.4%	-188.1%	248.9%	-56.0%	-6.7%	-3.9×	-0.16×	-4.07×	3.14×	0.0%	3	-3.77	2	C
CTMXCytomX Therapeutics, Inc.	$2.08	-28.4×	5.93×	7.71×	-36.76×	-283.4%	100.0%	-29.3%	-22.8%	-17.5%	-20.5%	-12.9%	0.04×	0.53×	0×	3.09×	0.0%	1	1.34	2	C
DRIODarioHealth Corp.	$2.34	-14.05×	8.32×	25.26×	-16.24×	-279.9%	56.6%	-163.9%	-186.6%	-61.4%	-36.2%	-4.6%	0.47×	-0.16×	-10.91×	3.73×	0.0%	3	-7.06	4	A-
EBSEmergent BioSolutions Inc.	$6.03	12.61×	1.27×	0.89×	4.32×	-48.4%	47.2%	14.8%	7.1%	10.1%	5.9%	23.7%	1.09×	1.54×	1.86×	5.01×	0.0%	4	0.4	1	C-
OLMAOlema Pharmaceuticals, Inc.	$7.24	-13.37×	4.55×	0×	-13.14×	-93.1%	0.0%	0.0%	0.0%	-33.9%	-37.0%	-6.7%	0×	0.29×	0×	9.95×	0.0%	2	4.21	2	C+
Peer median	—	-13.37×	4.55×	7.71×	-13.14×	-157.6%	56.6%	-29.3%	-22.8%	-17.5%	-36.2%	-6.7%	0.04×	0.29×	0×	3.73×	0.0%	3	0.4	2	—